Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.060 PosttranslationalModification disease BEFREE BK stimulation induced transient MARCKS phosphorylation on Ser159 with a peak at 1  min in human neuroblastoma SH-SY5Y cells. 21448919 2012
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.060 AlteredExpression disease BEFREE Expression of MARCKS effector domain mutants alters phospholipase D activity and cytoskeletal morphology of SK-N-MC neuroblastoma cells. 16341931 2005
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.060 Biomarker disease BEFREE Overexpression of the myristoylated alanine-rich C kinase substrate decreases uptake and K(+)-evoked release of noradrenaline in the human neuroblastoma SH-SY5Y. 11264665 2001
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.060 AlteredExpression disease BEFREE Overexpression of myristoylated alanine-rich C-kinase substrate enhances activation of phospholipase D by protein kinase C in SK-N-MC human neuroblastoma cells. 9601059 1998
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.060 Biomarker disease BEFREE To investigate the regulation of phorbol ester-stimulated synthesis of phosphatidylcholine (PtdCho), myristoylated alanine-rich protein kinase C substrate (MARCKS) and the alpha-isoform of protein kinase C (PKC-alpha) were overexpressed in a human neuroblastoma (SK-N-MC) cell line that does not increase PtdCho synthesis in response to 4beta-12-O-tetradecanoylphorbol 13-acetate (TPA). 8627336 1996
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.060 Biomarker disease BEFREE Amounts of MARCKS protein, measured by [3H]myristate labeling and western blotting, were severalfold higher in rat C6 glioma and human HTB-11 (SK-N-SH) neuroblastoma cells than in HTB-10 (SK-N-MC) or mouse N1E-115 neuroblastoma cells. 7964753 1994